Construction of circRNA–miRNA–mRNA Network Reveal Functional circRNAs and Key Genes in Acute Myeloid Leukemia

References

• Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra1406184
   PubMed Web of Science ®Google Scholar
• Pollyea DA, Bixby D, Perl A, et al. NCCN guidelines insights: acute myeloid leukemia, version 2.2021. J Natl Compr Canc Netw. 2021;19(1):16–27. doi:10.6004/jnccn.2021.0002
   PubMed Web of Science ®Google Scholar
• Webster JA, Luznik L, Gojo I. Treatment of AML relapse after Allo-HCT. Front Oncol. 2021;11:812207. doi:10.3389/fonc.2021.812207
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Su M, Xiao Y, Ma J, et al. Circular RNAs in cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Mol Cancer. 2019;18(1):90. doi:10.1186/s12943-019-1002-6
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Xiao-Long M, Chun-Lin Z. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci. 2018;14(3):321–330. doi:10.7150/ijbs.24360
   PubMed Web of Science ®Google Scholar
• Liu Y, Dong Y, Zhao L, Su L, Luo J. Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis. Int J Oncol. 2018;53(4):1752–1762. doi:10.3892/ijo.2018.4485
   PubMed Web of Science ®Google Scholar
• Chandran RK, Geetha N, Sakthivel KM, et al. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia. Gene. 2019;686:85–91. doi:10.1016/j.gene.2018.11.005
   PubMed Web of Science ®Google Scholar
• Gong Y, Mao J, Wu D, et al. Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. Cancer Cell Int. 2018;18:116. doi:10.1186/s12935-018-0602-3
   PubMed Web of Science ®Google Scholar
• Zhang L, Bu Z, Shen J, Shang L, Chen Y, Wang Y. A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A. Biomed Pharmacother. 2020;122:109619. doi:10.1016/j.biopha.2019.109619
   PubMed Web of Science ®Google Scholar
• Fleischmann M, Schnetzke U, Hochhaus A, Scholl S. Management of acute myeloid leukemia: current treatment options and future perspectives. Cancers. 2021;13(22):5722. doi:10.3390/cancers13225722
   PubMed Web of Science ®Google Scholar
• Li W, Zhong C, Jiao J, et al. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci. 2017;18(3):597. doi:10.3390/ijms18030597
   PubMed Web of Science ®Google Scholar
• Chen H, Liu T, Liu J, et al. Circ-ANAPC7 is upregulated in acute myeloid leukemia and appears to target the MiR-181 family. Cell Physiol Biochem. 2018;47(5):1998–2007. doi:10.1159/000491468
   PubMedGoogle Scholar
• Zhang S. The characteristics of circRNA as competing endogenous RNA in pathogenesis of acute myeloid leukemia. BMC Cancer. 2021;21(1):277. doi:10.1186/s12885-021-08029-7
   PubMed Web of Science ®Google Scholar
• Han F, Zhong C, Li W, et al. Hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis. Epigenomics. 2020;12(11):935–953. doi:10.2217/epi-2019-0352
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhou Y, Guan J, Cheng H. Circ_0058058 knockdown inhibits acute myeloid leukemia progression by sponging miR-4319 to regulate EIF5A2 expression. Cancer Biother Radiopharm. 2021;2021:1.
   Google Scholar
• Liu Y, Chen X, Liu J, Jin Y, Wang W. Circular RNA circ_0004277 inhibits acute myeloid leukemia progression through MicroRNA-134-5p / single stranded DNA binding protein 2. Bioengineered. 2022;13(4):9662–9673. doi:10.1080/21655979.2022.2059609
   PubMed Web of Science ®Google Scholar
• Luo N, Sulaiman Z, Wang C, et al. Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites. J Transl Med. 2022;20(1):201. doi:10.1186/s12967-022-03404-9
   PubMed Web of Science ®Google Scholar
• Wang X, Jin P, Zhang Y, Wang K. CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs. Cell Death Dis. 2021;12(4):297. doi:10.1038/s41419-021-03566-2
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Yang C, Liu J, Huang G. Upregulated circRNA ARHGAP10 predicts an unfavorable prognosis in NSCLC through regulation of the miR-150-5p/GLUT-1 axis. Mol Ther Nucleic Acids. 2019;18:219–231. doi:10.1016/j.omtn.2019.08.016
   PubMedGoogle Scholar
• Wang S, Tang D, Wang W, et al. circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer. Mol Cancer. 2019;18(1):162. doi:10.1186/s12943-019-1081-4
   PubMed Web of Science ®Google Scholar
• Cai H, Zhang P, Xu M, Yan L, Liu N, Wu X. Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR-150-5p. J Cell Physiol. 2019;234(7):11391–11400. doi:10.1002/jcp.27796
   PubMed Web of Science ®Google Scholar
• Ren L, Chen H, Song J, et al. MiR-454-3p-mediated Wnt/β-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics. 2019;9(2):449–465. doi:10.7150/thno.29055
   PubMed Web of Science ®Google Scholar
• Yan A, Wang C, Zheng L, Zhou J, Zhang Y. MicroRNA-454-3p inhibits cell proliferation and invasion in esophageal cancer by targeting insulin-like growth factor 2 mRNA-binding protein 1. Oncol Lett. 2020;20(6):359. doi:10.3892/ol.2020.12223
   PubMed Web of Science ®Google Scholar
• Zhang X, Ma N, Yao W, Li S, Ren Z. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer. Cancer Cell Int. 2019;19:356. doi:10.1186/s12935-019-1077-6
   PubMed Web of Science ®Google Scholar
• Wiegmans AP, Al-Ejeh F, Chee N, et al. Rad51 supports triple negative breast cancer metastasis. Oncotarget. 2014;5(10):3261–3272. doi:10.18632/oncotarget.1923
   PubMedGoogle Scholar
• Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res. 2004;10(8):2675–2680. doi:10.1158/1078-0432.CCR-03-0372
   PubMed Web of Science ®Google Scholar
• Park S, So MK, Huh J. Methylation of DNA repair genes as a prognostic biomarker in AML of a TCGA-LAML cohort. Clin Lab. 2022;68(7). doi:10.7754/Clin.Lab.2021.211025
   Web of Science ®Google Scholar
• Xie C, Drenberg C, Edwards H, et al. Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51. PLoS One. 2013;8(11):e79106. doi:10.1371/journal.pone.0079106
   PubMed Web of Science ®Google Scholar
• Yusenko MV, Trentmann A, Andersson MK, et al. a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells. Cancer Lett. 2020;479:61–70. doi:10.1016/j.canlet.2020.01.039
   PubMed Web of Science ®Google Scholar
• Park S, Chapuis N, Tamburini J, et al. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica. 2010;95(5):819–828. doi:10.3324/haematol.2009.013797
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Womble M, Qiu YH, et al. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood. 2006;108(7):2358–2365. doi:10.1182/blood-2006-02-003475
   PubMed Web of Science ®Google Scholar
• Zhou C, Du J, Zhao L, et al. GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia. Cell Death Dis. 2021;12(3):231. doi:10.1038/s41419-021-03504-2
   PubMed Web of Science ®Google Scholar
• Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells. Blood Cells Mol Dis. 2013;51(3):177–184. doi:10.1016/j.bcmd.2013.05.003
   PubMed Web of Science ®Google Scholar
• Yang C, Shao T, Zhang H, et al. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. J Transl Med. 2018;16(1):267. doi:10.1186/s12967-018-1647-8
   PubMedGoogle Scholar
• Dou B, Jiang Z, Chen X, et al. Oncogenic long noncoding RNA DARS-AS1 in childhood acute myeloid leukemia by binding to microRNA-425. Technol Cancer Res Treat. 2020;19:1533033820965580. doi:10.1177/1533033820965580
   Web of Science ®Google Scholar
• Yu J, Li Y, Pan Y, et al. Deficient regulatory innate lymphoid cells and differential expression of miRNAs in acute myeloid leukemia quantified by next generation sequence. Cancer Manag Res. 2019;11:10969–10982. doi:10.2147/CMAR.S234327
   PubMed Web of Science ®Google Scholar